Human body is a complex electrical system. With the traditional bioelectronic medicines, the intricate electrical signals of the body can be manipulated to control disorders and restore quality of life for millions. But these methods have mostly been limited to treating symptoms rather than attacking the root cause of problems.
With recent research in bioelectronic medicines this is changing rapidly. While electrical devices are still being used to complement or replace pharmaceuticals, the aim is shifting towards treating the root causes rather than masking symptoms of disorders.
One key area of research is around monitoring healthy people and collecting statistically-significant data before the onset of symptoms and identifying the subtle changes in the body’s electrical system before disorders happen. If a baseline can be accomplished to define what “healthy” means, then bioelectronic medicines may be able to restore a body to its healthy state through electrical stimulation.
Thanks to recent advances in low-cost, low-power microelectronics and ultra device miniaturization, medical devices with closed-loop signal monitoring capabilities can deliver high-precision stimulation for personalized bioelectronic medicine.
Fully-programmable devices further facilitate personal medicine by enabling precision customization and fine-tuning through simple adjustments by software.
When empowered by wireless technologies and IoMT (Internet of Medical Things) capabilities that connect devices to the cloud, new bioelectronic medicines bridge care givers and their patients directly, to deliver personalized care to ANYONE, ANYWHERE, and ANYTIME, improving safety, efficacy, and quality of healthcare, improve patient outcomes, lower costs, and eventually eradicate many debilitating disorders once and for all.
Lone Star NeuroMODULATION
LSN is targeting unmet clinical needs by creating disruptive device platforms that offer promising solutions for lowering costs, realizing higher returns and effectively addressing more therapeutic indications if adopted for medical applications.